2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Sunday, April 30, 2017

6:00pm-7:00pm: Daratumumab for Severe Refractory Proliferative Glomerulonephritis with Monoclonal Immune Deposits (PGNMID).

S. Anand,^1,3 D. Miller,¹ G. Chipman,² D. Morris,^1,3 T. Srinivas.¹

Poster Session B: Kidney Complications II • Hall D1

6:00pm-7:00pm: De Novo Malignancy Occurrence After Kidney Transplantation in HLA-Sensitized Patients Treated with B-Cell Targeting Therapy.

L. Couzi,^1,2,3 P. Davis,¹ J. Visentin,^1,2,3 B. Taton,¹ G. Guidicelli,¹ H. Kaminski,^1,2,3 P. Merville,^1,2,3 T. Bachelet.⁴

Poster Session B: Kidney Immunosuppression: Induction Therapy • Hall D1

6:00pm-7:00pm: Deleting LAG-3 Accelerates Cardiac Allograft Rejection and Augments T Cell Memory in Mice.

J. Erfe,^1,2 C. Yang,¹ D. Ndishabandi,¹ I. Rosales,¹ R. White,¹ P. Russell,¹ R. Colvin,¹ J. Madsen,¹ A. Alessandrini.¹

Poster Session B: Acute and Chronic Rejection • Hall D1

6:00pm-7:00pm: Describing the Effects of the Antibiotic Regimen Immediate Post Multi-Visceral Transplant in the Pediatric Population on the Time to First Serious Bacterial Infection.

B. Chatani,¹ J. Garcia,² C. Biaggi,² T. Beduschi,³ A. Tekin,³ R. Vianna,⁴ I. Gonzalez.⁵

Poster Session B: Bacteria, Fungi, Parasites • Hall D1

6:00pm-7:00pm: Desensitization Regimen for the Patients with High Isoagglutinin Titers to Undergo Adult ABO-Incompatible Living Donor Liver Transplantation.

W.-C. Lee, C.-F. Lee, T.-H. Wu, Y.-C. Wang, C.-H. Cheng, T.-J. Wu, H.-S. Chou, K.-M. Chan.

Poster Session B: Living Donors and Partial Grafts • Hall D1

6:00pm-7:00pm: Development of Transplant Glomerulopathy in Recipients with Antibody Mediated Rejection: Activation of Inflammatory Pathway Through Renal Poly (ADP-Ribose) Polymerase (PARP).

B. Ozdemir,¹ F. Ozdemir,² E. Baskin,² M. Haberal.³

Poster Session B: Antibody Mediated Rejection in Kidney Transplant Recipients II • Hall D1

6:00pm-7:00pm: Diabetes in Liver Transplantation: Evaluation of Management and Associated Clinical Outcomes.

A. Rogers,² N. Patel,² H. Meadows,² A. Mardis,² J. Fleming,² C. Perez,² I. Lee,² M. Sell,² B. O'Brien,² D. Taber,¹ K. Chavin,¹ D. Dubay,¹ C. Mardis,² N. Pilch.¹

Poster Session B: Liver Retransplantation and Other Complications • Hall D1

6:00pm-7:00pm: Differences in Kinetics of IFN-y Production Between Endogenous and Allotransplant-Induced Memory T Cells.

B. Gonzalez-Nolasco, J. Marino, W. Orent, G. Benichou.

Poster Session B: Acute and Chronic Rejection • Hall D1

6:00pm-7:00pm: Digital Image Analysis of Pediatric Liver Allograft Biopsies Correlates with METAVIR Fibrosis Score.

R. Fischer,¹ S. Foster,² J. Daniel,¹ R. Hendrickson,¹ W. Andrews,¹ A. Kats.¹

Poster Session B: Pediatric Liver Transplant - Clinical • Hall D1

6:00pm-7:00pm: Distinctive Molecular Features of Antibody-Mediated versus T-Cell Mediated Rejection in Facial Transplantation.

R. Lopdrup, T. Win, N. Murakami, J. Teague, A. Chandraker, G. Murphy, C. Lian, E. Bueno, B. Pomahac, R. Clark, L. Riella.

Poster Session B: VCA • Hall D1